How Entrepreneurs are Leading Their Companies Through an Unexpected Year

Episode Summary

Executive Summary: Goldman Sachs’ Builders and Innovators Summit featured Bowery Farming’s Irving Fain and Gossamer Bio’s Sheila Gujarati discussing why they founded their companies, how COVID-19 accelerated or complicated their work, and how technology is reshaping food production and drug development. Kim Posnett emphasized that resilience, culture, and technology are now essential across all industries.

Main Topics: Founder origins and mission (Priority: 5/5): Both founders explained how their personal experience and values led them to build companies aimed at solving major societal problems: sustainable urban agriculture at Bowery and next-generation therapeutics at Gossamer Bio. Technology as an operational advantage (Priority: 5/5): The discussion highlighted how software, AI, robotics, data, and translational science are central to scaling both companies and improving outcomes, not merely supporting them. COVID-19 as accelerator and stress test (Priority: 5/5): The pandemic disrupted clinical trials and in-person collaboration at Gossamer, while also accelerating Bowery’s growth by heightening concern about food supply-chain safety and reliability. Innovation under resource constraints (Priority: 4/5): Sheila described the capital intensity and high failure rates of biotech, while Irving described the scale challenges of rethinking agriculture; both stressed focus, expertise, and execution. Entrepreneurship, culture, and talent (Priority: 4/5): Kim Posnett and both founders argued that strong culture, the right people, humility, and resilience are decisive factors in building enduring companies. Future of sustainable food and better medicine (Priority: 5/5): The panel expressed optimism that indoor farming and translational biotech can reduce uncertainty, improve sustainability, and deliver better products and therapies at scale.

Key Arguments: Bowery Farming argues that controlled indoor agriculture can produce fresher, safer, more water-efficient food near cities while reducing reliance on fragile long-distance supply chains. Gossamer Bio argues that combining biotech agility with pharma-quality rigor enables faster, more focused development of novel therapies in immunology, inflammation, and oncology. COVID-19 exposed vulnerabilities in both healthcare and food systems, but it also accelerated adoption of solutions that were already structurally needed. Technology is no longer optional or sector-specific; it is becoming a core driver of competitiveness across industries, according to Kim Posnett. In biotech, small firms must be exceptionally disciplined because resource-intensive trials and high attrition rates leave little room for error. In entrepreneurship, personal conviction, strong teams, and humility are essential because the journey is long, uncertain, and highly dependent on execution. Both speakers believe the future will favor more regionalized, resilient systems—whether in food production or drug discovery—supported by data and advanced tools.

Data Points: Indoor farm productivity: 100+ times more productive - Irving Fain described Bowery as producing more crops per square foot than traditional farmland. Water usage: A fraction of traditional agriculture - Bowery’s indoor farms use significantly less water than conventional farming. Growing cycle: 365 days per year - Bowery farms can grow continuously regardless of seasons. Pesticide use: Completely pesticide free - Bowery emphasized its pesticide-free production model. Global water use by agriculture: 70% - Irving cited agriculture’s share of the world’s annual water usage. Annual pesticide application: About 6 billion pounds - Irving used this figure to illustrate the environmental burden of conventional agriculture. Loss of arable land: 30% over the last 40 years - Irving noted long-term degradation of farmland. Population growth outlook: 9 to 10 billion people - Projected global population over the next 30 years. Additional food required: 50% to 70% more food - UN-based estimate cited by Irving for feeding the future population. Urbanization outlook: 70% to 80% of people in and around cities - Irving highlighted the need to supply fresh food to urban populations. Bowery growth: Over 600% growth in 2020 - Irving said the company experienced major pandemic-era acceleration. Retail footprint: Under 100 stores to over 680 stores - Bowery expanded distribution significantly during the year. Gossamer exit reference: $7.2 billion - Sheila cited the sale of Receptos to Celgene in 2015 as a major prior milestone. Podcast recording date: Thursday, October 15, 2020 - The episode was recorded during the pandemic.

Pivotal Quotes: "the company of my dreams" — Sheila Gujarati: She described why she founded Gossamer Bio and how it combined her experience, team, and vision. "technology is critical to the future in every respect" — Kim Posnett: She argued that every company will need to meaningfully leverage technology to win. "we can have the most amazing technology in the world. If the food that we grow doesn't taste incredible, it doesn't matter" — Irving Fain: He stressed that Bowery’s tech must ultimately deliver delicious, appealing food.

Implications: The conversation suggests the next generation of winners will pair mission-driven leadership with deep technology, resilient culture, and operational discipline. In food and biotech especially, COVID accelerated demand for safer, more reliable, data-enabled systems.